Houston-based CNS Pharmaceuticals is combining an unusual financing method with some interesting chemistry to expand the therapeutic choices for glioblastoma patients. The company is using crowdfunding to bridge the gap between an early friends and family round and their IPO, which is slated for summer. The ultimate goal is move their blood-brain barrier-penetrating chemotherapy, berubicin, into a phase 2 glioblastoma trial.
Glioblastoma has become famous both for the lives it's taken - including Senator Ted Kennedy and former Vice President Joe Biden's son Beau - and the grimness of the...
The comment you're trying to see no longer exists.
Republic does not verify information provided by companies on this Portal and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Portal can be found by searching the EDGAR database.